Symbiosis Ip Limited opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Symbiosis Ip Limited

Patent Number:
Title:
Combination Of A Pd-1 Antagonist And A Vegfr Inhibitor For Treating Cancer
Opposition Date:
May 26, 2022
Patent Number:
Title:
Blood-Based Biomarkers Of Tumor Sensitivity To Pd-1 Antagonists
Opposition Date:
Sep 15, 2021

Want to track Symbiosis Ip Limited?

Feel free to send us a message here and we will get back to you